Sarecycline Seysara denied for failing step therapy by Blue Cross Blue Shield?
Step-therapy denials usually flip when the appeal documents that prior alternatives were tried and failed, or were contraindicated, or aren't safe for the patient.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Blue Cross Blue Shield typically requires
Blue Cross Blue Shield's specific coverage criteria for sarecycline seysara are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Blue Cross Blue Shield angle on Sarecycline Seysara
## Why BCBS Denied Sarecycline (Seysara) Under Step Therapy
Blue Cross Blue Shield uses step therapy — sometimes called "fail first" — as a coverage requirement for sarecycline. This means the plan requires documented evidence that you have already tried and failed, or are unable to tolerate, one or more lower-tier antibiotic treatments for acne before it will approve sarecycline. The underlying rationale is cost management: BCBS wants assurance that less expensive alternatives were tried first. If that prior-treatment history was not included in the original submission, or if the history was not accepted as adequate, the claim is denied.
### Why This Denial Is Appealable
Step therapy requirements are appealable in several situations: (1) you have already completed the required steps and the documentation simply was not submitted; (2) one or more required prior drugs are contraindicated or clinically inappropriate for you, and your prescriber can document why; or (3) you experienced a prior adverse effect that makes a required step unsafe. Many states also have step-therapy override laws that require plans to grant exceptions when the required prior drug is clinically inappropriate. Check whether your state has enacted such a law, as it may strengthen your appeal.
### Federal Appeal Framework
- Internal appeal: File under ERISA §503 (employer plans) or ACA §2719 (individual/small-group plans). The deadline is on your denial notice — typically 180 days.
- External review: After an adverse internal decision, request independent external review under ACA §2719, generally within about four months of the final internal denial.
- State-law step-therapy exception: If your state has a step-therapy exception statute, cite it explicitly in your appeal letter.
- Expedited review: Available if the condition warrants urgent treatment; request in writing.
### Concrete Appeal Steps
1. Obtain BCBS's step-therapy protocol for sarecycline — the specific drugs required as prior steps and the documentation of failure or intolerance they will accept. 2. Gather pharmacy records and chart notes documenting each prior step that was attempted, with dates and documented reason for stopping. 3. If a required step was never tried because it was clinically inappropriate, have your prescriber write a letter explaining why, citing the clinical reason (intolerance history, contraindication documented in the chart, etc.). 4. Have your prescriber submit a step-therapy exception request with the clinical documentation. 5. If denied, file the internal appeal and, if needed, external review.
### Documentation to Gather
- Prior-treatment history: Pharmacy records and chart notes for each required prior step, with start/stop dates and documented outcomes or adverse effects.
- Step exception rationale (if steps not completed): Prescriber letter explaining, drug by drug, why each required step was clinically inappropriate or contraindicated.
- Diagnosis and severity documentation: Chart notes confirming current disease severity requiring systemic antibiotic treatment.
- Prescriber medical-necessity letter: Addresses each step-therapy criterion with specific, dated chart facts.
- Criteria mapping: Two-column format — left column: each step requirement verbatim from BCBS's policy; right column: the chart evidence satisfying or excepting each step.
### Key Reminder
Step-therapy criteria are found in BCBS's published drug coverage or utilization-management policy. Retrieve the current version that applies to your plan year and cross-reference every required step before preparing documentation.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →Related appeal guides
- Blue Cross Blue Shield denied for failing step therapy of 17ohp Compounded
- Blue Cross Blue Shield denied for failing step therapy of AAT Augmentation
- Blue Cross Blue Shield denied for failing step therapy of Amphetamine Stimulant Prodrug
- Blue Cross Blue Shield denied for failing step therapy of Anti Cd 20 Ocrevus